Picture of SensaSure Technologies logo

SSTC SensaSure Technologies Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1mn/a
3mn/a
6mn/a
1yrn/a
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Margin-123834.78%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Apr 202430th Apr 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of SensaSure Technologies EPS forecast chart

Profile Summary

SensaSure Technologies, Inc. is a medical technology company. The Company is engaged in supplying a device and method to collect a breath sample for lab-based analysis. The Company's method is known as ExaBreath (EB) and it can collect, extract, detect and identify non-volatile compounds present in every exhaled breath by utilizing existing lab-based testing infrastructure and procedures. EB is applicable in toxicology, pharmacology, and clinical biochemistry. EB enhances the user experience in a range of applications and markets, such as workplace drug testing, anti-doping in sports, law enforcement, e-health, and telemedicine. The Company's testing methodology is a non-invasive way to collect chemicals in breath, for disease detection, exposure monitoring, and drug metabolism. EB detects a range of exogenous substances, such as drugs of abuse (narcotics), therapeutic drugs (antibiotics), and performance-enhancing drugs used in sports (stimulants), as well as many other compounds.

Directors

    Last Annual
    April 30th, 2023
    Last Interim
    January 31st, 2024
    Incorporated
    September 8th, 2020
    Public Since
    December 1st, 2022
    No. of Employees
    1
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    us flag iconPink Sheets on Nasdaq
    Shares in Issue
    56,349,183

    SSTC Share Price Performance

    Similar to SSTC

    Picture of Acorda Therapeutics logo

    Acorda Therapeutics

    us flag iconPink Sheets on Nasdaq

    Picture of Actavia Life Sciences logo

    Actavia Life Sciences

    us flag iconPink Sheets on Nasdaq

    Picture of Acura Pharmaceuticals logo

    Acura Pharmaceuticals

    us flag iconPink Sheets on Nasdaq

    Picture of Adhera Therapeutics logo

    Adhera Therapeutics

    us flag iconPink Sheets on Nasdaq

    Picture of Ramoil Management logo

    Ramoil Management

    us flag iconPink Sheets on Nasdaq

    FAQ